Cencora, Inc.

COR Healthcare Medical Distribution

Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.

340.66 0.75 −0.22%
Market cap
$65.2B
P/E
25.2×
Fwd P/E
14.5×
Dividend yield
0.70%
F-score
6/9
Altman Z
4.83
Beneish M
−2.54
Dividend safety
74/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21 Sep '22 Sep '23 Sep '24 Sep '25
Cash and Short Term Investments
2,741.83 2,435.12 2,492.52 3,374.19 4,597.75 2,547.14 3,388.19 2,592.05 3,132.65 4,356.14
Receivables
9,175.88 10,303.32 11,314.23 12,392.74 14,334.73 18,389.05 18,625.24 20,988.20 23,871.81 25,225.30
Inventory
10,723.92 11,461.43 11,918.51 11,060.25 12,589.28 15,368.35 15,556.39 17,454.77 18,998.83 20,492.48
Other current assets
184.00 103.00 169.00 163.00 189.00 372.91 — — — —
Total current assets
22,851.85 24,303.30 25,894.37 28,132.05 33,055.70 38,802.61 39,589.76 42,798.82 47,717.81 52,239.07
Property, Plant, Equpment (Net)
1,530.68 1,797.95 1,892.42 1,770.52 1,484.81 2,162.96 2,135.00 2,135.17 2,181.41 2,539.08
Goodwill and Intangible Assets (Total)
8,959.35 8,877.56 9,612.10 9,000.34 8,592.83 14,287.46 12,836.62 14,005.90 13,319.07 17,450.70
Long Term Assets (Tax, Deferred)
— — — — 361.64 290.79 237.57 200.67 246.35 208.81
Long-term assets (Other)
295.63 337.66 270.94 269.07 779.85 1,793.99 1,761.66 3,418.18 3,637.02 4,152.45
Total non-current assets
10,785.65 11,013.17 11,775.47 11,039.93 11,219.13 18,535.20 16,970.86 19,759.92 19,383.85 24,351.04
Total Assets
33,637.50 35,316.47 37,669.84 39,171.98 44,274.83 57,337.80 56,560.62 62,558.75 67,101.66 76,590.11
Accounts Payable
23,926.32 25,404.04 26,836.87 28,385.07 31,705.05 38,009.95 40,192.89 45,836.04 50,942.16 54,719.76
Accrued Expenses
743.84 1,402.00 881.16 1,057.21 1,646.76 2,856.41 2,214.59 2,353.82 2,758.56 2,982.99
Current Part of Debt
610.21 12.12 151.66 139.01 501.26 300.21 1,070.47 641.34 576.33 117.79
Other current liabilities
744.00 1,402.00 881.00 1,057.00 1,554.00 192.07 — — — —
Total current liabilities
25,280.37 26,818.16 27,869.69 29,581.29 33,853.08 41,358.64 43,477.95 48,831.20 54,277.05 57,820.54
Long Term Debt (Total)
3,852.48 3,781.57 4,510.83 4,354.40 3,618.26 6,383.71 4,632.36 4,146.11 3,811.75 7,542.99
Long Term Tax Liability (Deferred)
2,214.77 2,492.61 1,829.41 1,860.20 686.49 1,685.30 1,620.41 1,657.94 1,643.75 1,620.72
Non-current Liabilities (Other)
160.47 159.66 409.95 382.89 6,956.64 7,325.75 6,758.62 7,257.20 6,582.38 7,858.78
Total non-current liabilities
6,227.73 6,433.84 6,750.19 6,597.48 11,261.39 15,394.75 13,011.39 13,061.26 12,037.87 17,022.49
Total liabilities
31,508.10 33,252.01 34,619.88 36,178.77 45,114.46 56,753.39 56,489.34 61,892.46 66,314.92 74,843.02
Additional Paid In Capital
4,333.00 4,517.64 4,715.47 4,850.14 5,081.78 5,465.10 5,658.73 5,844.58 6,030.79 6,204.30
Common Stock (Net)
2.78 2.81 2.84 2.85 2.88 2.91 2.93 2.95 2.96 2.97
Retained Earnings
2,303.94 2,395.22 3,720.58 4,235.49 518.34 1,670.51 2,977.65 4,324.19 5,417.14 6,534.23
Treasury Stock
4,396.01 4,755.35 5,426.81 6,097.60 6,513.08 6,469.73 7,019.90 8,247.10 9,815.84 10,332.11
Common Equity (Total)
2,129.40 2,064.46 3,049.96 2,993.21 (839.64) 584.41 71.27 666.29 786.74 1,747.09
Shareholders Equity (Total)
2,129.40 2,064.46 3,049.96 2,993.21 (839.64) 584.41 71.27 666.29 786.74 1,747.09
Shareholders Equity and Liabilities (Total)
33,637.50 35,316.47 37,669.84 39,171.98 44,274.83 57,337.80 56,560.62 62,558.75 67,101.66 76,590.11
Shares (Common)
220.05 217.99 213.22 206.76 204.23 208.09 206.20 200.82 194.94 193.94
Shareholders Equity (Tangible)
(6,829.94) (6,813.10) (6,562.14) (6,007.14) (9,432.46) (13,703.05) (12,765.35) (13,339.62) (12,532.33) (15,703.62)
Net Debt
1,720.86 1,358.58 2,169.97 1,119.22 (478.23) 4,136.78 2,314.64 2,195.41 1,255.43 3,304.64
Total Debt
4,462.69 3,793.69 4,662.49 4,493.41 4,119.52 6,683.92 5,702.83 4,787.46 4,388.08 7,660.77

Fold the line items

In millions of $ except per-share values · columns are period end dates